Demonstration venue · read-only. Every page can be browsed; the buttons that would change it are switched off. Create an account to run TaxoReview on your own data. A simulation from public publication records: the people listed were not invited and did not agree to review.
? Tutorial for this page

Christopher E. Gillies

dblp:05/10089 · DBLP profile ↗
← Back
5ranked-venue papers
5as first author
0since 2021 · last 2020
0000-0002-5290-3880ORCID · corroborated

Domains — the database's venue-derived domains; a paper can count in several

Applied, interdisciplinary, general and emerging computing · 4 · 4 first-author

Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.

Interdisciplinary, comprehensive, and emerging computing
1 paper
Bioinformatics and computational biology · 56% Medical and health informatics · 44%

Topics — the 2 heaviest of 3, each with the papers that count most for it

TopicWeightPapersLastEvidence papers
Medical and health informatics › clinical diagnosis
rare disease diagnosis
0.212015
GeneVetter: a web tool for quantitative monogenic assessment of rare diseases · Bioinform. 2015
Bioinformatics and computational biology › statistical genetics › variant effect prediction
variant pathogenicity prediction
0.212015
GeneVetter: a web tool for quantitative monogenic assessment of rare diseases · Bioinform. 2015

Methods — techniques the papers use, named apart from their topics

power calculation · 0.2
YearPublicationVenuePosition
2020 Demonstrating the consequences of learning missingness patterns in early warning systems for preventative health care: A novel simulation and solution
Christopher E. Gillies, Daniel F. Taylor, Brandon C. Cummings, Sardar Ansari, Fadi Islim, Steven L. Kronick, Richard P. Medlin Jr., Kevin Ward
J. Biomed. Informatics1
2016 tarSVM: Improving the accuracy of variant calls derived from microfluidic PCR-based targeted next generation sequencing using a support vector machine
abstract
BACKGROUND: Targeted sequencing of discrete gene sets is a cost effective strategy to screen subjects for monogenic forms of disease. One method to achieve this pairs microfluidic PCR with next generation sequencing. The PCR step of this pipeline creates challenges in accurate variant calling. This includes that most reads targeting a specific exon are duplicates that have been amplified from the PCR step. To reduce false positive variant calls from these experiments, previous studies have used threshold-based filtering of alternative allele depth ratio and manual inspection of the alignments. However even after manual inspection and filtering, many variants fail to be validated via Sanger sequencing. To improve the accuracy of variant calling from these experiments, we are challenged to design a variant filtering strategy that sufficiently models microfluidic PCR-specific issues. RESULTS: We developed an open source variant filtering pipeline, targeted sequencing support vector machine ("tarSVM"), that uses a Support Vector Machine (SVM) and a new score the normalized allele dosage test to identify high quality variants from microfluidic PCR data. tarSVM maximizes training knowledge by selecting variants that are likely true and likely false variants by incorporating knowledge from the 1000 Genomes and the Exome Aggregation Consortium projects. tarSVM improves on previous approaches by synthesizing variant features from the Genome Analysis Toolkit and allele dosage information. We compared the accuracy of tarSVM versus existing variant quality filtering strategies on two cohorts (n = 474 and n = 1152), and validated our method on a third cohort (n = 75). In the first cohort, our method achieved 84.5 % accuracy of predicting whether or not a variant would be validated with Sanger sequencing versus 78.8 % for the second most accurate method. In the second cohort, our method had an accuracy of 73.3 %, versus 61.5 % for the second best method. Finally, our method had a false discovery rate of 5 % for the validation cohort. CONCLUSIONS: tarSVM increases the accuracy of variant calling when using microfluidic PCR based targeted sequencing approaches. This results in higher confidence downstream analyses, and ultimately reduces the costs Sanger validation. Our approach is less labor intensive than existing approaches, and is available as an open source pipeline for read trimming, aligning, variant calling, and variant quality filtering on GitHub at https://github.com/christopher-gillies/TargetSpecificGATKSequencingPipeline .
Christopher E. Gillies, Edgar A. Otto, Virginia Vega-Warner, Catherine C. Robertson, Simone Sanna-Cherchi, Ali Gharavi, Brendan Crawford, Rajendra Bhimma, Cheryl A. Winkler, Hyun Min Kang, Matthew G. Sampson
BMC Bioinform.1
2015 GeneVetter: a web tool for quantitative monogenic assessment of rare diseases
abstract
UNLABELLED: When performing DNA sequencing to diagnose affected individuals with monogenic forms of rare diseases, accurate attribution of causality to detected variants is imperative but imperfect. Even if a gene has variants already known to cause a disease, rare disruptive variants predicted to be causal are not always so, mainly due to imperfect ability to predict the pathogenicity of variants. Existing population-scale sequence resources such as 1000 Genomes are useful to quantify the 'background prevalence' of an unaffected individual being falsely predicted to carry causal variants. We developed GeneVetter to allow users to quantify the 'background prevalence' of subjects with predicted causal variants within specific genes under user-specified filtering parameters. GeneVetter helps quantify uncertainty in monogenic diagnosis and design genetic studies with support for power and sample size calculations for specific genes with specific filtering criteria. GeneVetter also allows users to analyze their own sequence data without sending genotype information over the Internet. Overall, GeneVetter is an interactive web tool that facilitates quantifying and accounting for the background prevalence of predicted pathogenic variants in a population. AVAILABILITY AND IMPLEMENTATION: GeneVetter is available at http://genevetter.org/ CONTACT: [email protected] or [email protected] SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
Christopher E. Gillies, Catherine C. Robertson, Matthew G. Sampson, Hyun Min Kang
Bioinform.1
2013 A simulation to analyze feature selection methods utilizing gene ontology for gene expression classification
Christopher E. Gillies, Mohammad-Reza Siadat, Nilesh V. Patel, George D. Wilson
J. Biomed. Informatics1
2011 Minimum Steiner Tree for Automatic SQL Query Generation Applied on a Medical Record Database
abstract
The size and complexity of medical record databases makes extracting information challenging. With the tables numbering in thousands, even database analysts have trouble finding important fields and discovering various associations between tables. This paper presents a case study of our initial method of finding minimum Steiner trees in the Epic Clarity Reporting database to solve this problem. In addition, we present a web service architecture that can be used to extend our approach to multiple databases.
Christopher E. Gillies, Nilesh V. Patel, Gautam B. Singh, Serge G. Kruk, Eddie Cheng 0001, George D. Wilson
SERVICES1